Synthesis and antitumor activity evaluation of 4,6-disubstituted quinazoline derivatives as novel PI3K inhibitors

Bioorg Med Chem Lett. 2016 Sep 15;26(18):4408-4413. doi: 10.1016/j.bmcl.2016.08.015. Epub 2016 Aug 8.

Abstract

A series of 4,6-disubstituted quinazoline derivatives as potential PI3K inhibitors were designed and synthesized. All compounds exhibited significant anti-proliferative activities against HCT-116 and MCF-7 cell lines, and compounds A7, A9, and A11 displayed the most potent anti-proliferative activity against the HCT-116. Further PI3K inhibitory activity evaluation showed that compound A7 displayed high potency against PI3K enzymes. The in vivo anti-tumor study showed compound A7 can efficaciously inhibit tumor growth in a mice S-180 model. These results suggest that our designed compounds can serve as potent PI3K inhibitors and effective antitumor agents.

Keywords: Anti-proliferative; Antitumor; PI3K inhibitor; Quinazoline derivatives; Synthesis.

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Drug Screening Assays, Antitumor
  • Enzyme Inhibitors / pharmacology*
  • HCT116 Cells
  • Humans
  • MCF-7 Cells
  • Phosphoinositide-3 Kinase Inhibitors*
  • Quinazolines / pharmacology*

Substances

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Phosphoinositide-3 Kinase Inhibitors
  • Quinazolines